Researchers discover a decline in glucose levels in the brain that occurs during the early stages of MCI.
A new technique may offer superior predictions for the outcomes of diseases with a genetic component, from Alzheimer's disease to depression.
Researchers have identified 40 new genes they believe are related to aggressive behavior in both humans and mice. The findings deepen understanding of the genetic basis of aggressiveness.
Researchers have successfully activated the brain's opioid receptors using optogenetics.
A new study provides a possible explanation as to what causes cognitive and memory problems associated with chemotherapy treatments.
Activity of the c-Fos gene begins the increase on the ninth day of exposure to antidepressants. By day 14, mice showed behavioral changes associated with SSRI use. This may explain why suicide rates drop after nine days of treatment, and symptoms of depression improve after three weeks.
A new study supports p38α MAPK as a possible clinical target for treating central nervous system disorders associated with uncontrolled brain inflammation, including TBI.
Researchers have identified key underlying biological processes that involve some of the hundreds of genes known to contribute to the risk of autism spectrum disorders.
Researchers report neurons record their activity in gene expression, and the activity record can be reconstructed by analyzing gene expression patterns.
A new study finds wine-derived human gut metabolites may have neuroprotective capabilities.
Findings could open new avenues for designing drugs to treat ataxia, researchers report.
Researchers discovered a bacteria of the genus Bartonella releases a protein, which they dubbed BafA, which stimulates the production of new blood vessels that support bacterial lesions. Bartonella henselae causes cat scratch disease. The findings provide new insight into the mechanisms by which infectious bacteria can produce lesions.
